Safeguard Scientifics, Inc. SFES
0.41
0.00
0.00%
as of 25 Sep
- Market cap
- $7.5M
- P/E
- 0.4×
Follow SFES
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
8.07 | 40.00 | 10.06 | 9.56 |
+8 more quarters Free account |
Net Debt/EBITDA |
10.25 | 66.25 | 20.84 | 16.92 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.01 | (0.01) | 0.57 | (0.20) | |
Capex/Depreciation |
— | — | 0.00 | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.02) | (0.01) | (0.02) | |
Cash per Share |
0.29 | 1.71 | 0.54 | 0.55 | |
Shareholders Equity per Share |
0.37 | 1.79 | 0.69 | 0.71 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.37 | 1.79 | 0.69 | 0.71 | |
Free Cash Flow |
(0.51) | (0.25) | (0.16) | (0.33) | |
Working Capital |
4.33 | 28.00 | 8.30 | 8.52 | |
Net Current Asset Value |
4.33 | 27.95 | 8.25 | 8.47 | |
| Other line items | |||||
Quick Ratio |
7.90 | 39.86 | 9.80 | 9.18 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.03) | (0.02) | (0.01) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.14 | 0.15 | 0.16 | 0.12 | |
Average Assets |
9.09 | 20.51 | 11.91 | 14.93 | |
Average Common Equity |
8.20 | 19.48 | 10.69 | 13.59 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates